Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study

Lancet

Volumn 354, Issue 9192, 1999, Pages 1771-1775

  Schrag, A ^a   Ben Shlomo, Y ^b   Quinn, N P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; GENERAL PRACTICE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL RECORD; PARKINSON DISEASE; PATHOLOGY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; UNITED KINGDOM; VIDEORECORDING;

EID: 0033589692     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04137-9     Document Type: Article

References (27)

1. Rajput A.H., Rozdilsky B., Rajput A. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci. 18:1991;275-278.
2. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 42:1992;1142-1146.
3. Wenning G.K., Ben-Shlomo Y., Magalhaes M., Daniel S.E., Quinn N.P. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 58:1995;160-166.
4. Maraganore D.M., Anderson D.W., Bower J.H., McDonnell S.K., Rocca W.A. Potential bias in autopsy series of Parkinson's disease and related disorders. Neurology. 50:1998;98.
5. Tandberg E., Larsen J.P., Nessler E.G., Riise T., Aarli J.A. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord. 10:1995;541-549.
6. Morgante L., Rocca W.A., Di Rosa A.E.et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities - The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 42:1992;1901-1907.
7. Cockerell O.C., Goodridge D.M., Brodie D., Sander J.W., Shorvon S.D. Neurological disease in a defined population: the results of a pilot study in two general practices. Neuroepidemiology. 15:1996;73-82.
8. Cockerell O.C., Sander J.W., Shorvon S.D. Neuroepidemiology in the United Kingdom. J Neurol Neurosurg Psychiatry. 56:1993;735-758.
9. Litvan I., Agid Y., Calne D.et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 47:1996;1-9.
10. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry. 1989;78-89. Suppl.
11. Eurostat Data Shop. London: Office for National Statistics, 1997.
12. Smith P. Comparison between registries: age-standardized rates. Muir C., Waterhouse J., Mack J., Powell J., Whelan S. Cancer incidence in five continents, vol V. 1987;790-795 IARC Scientific Publications, Lyon.
13. Litvan I., Mangone C.A., McKee A.et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 60:1996;615-620.
14. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology. 49:1997;1284-1288.
15. Wenning G.K., Ben-Shlomo Y., Magalhaes M., Daniel S.E., Quinn N.P. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain. 117:1994;835-845.
16. Trenkwalder C., Schwarz J., Gebhard J.et al. Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol. 52:1995;1017-1022.
17. Tison F., Dartigues J.F., Dubes L., Zuber M., Alperovitch A., Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand. 90:1994;111-115.
18. Golbe L.I., Davis P.H., Schoenberg B.S., Duvoisin R.C. Prevalence and natural history of progressive supranuclear palsy. Neurology. 38:1988;1031-1034.
19. Wermuth L., Joensen P., Bunger N., Jeune B. High prevalence of Parkinson's disease in the Faroe Islands. Neurology. 49:1997;426-432.
20. Chio A., Magnani C., Schiffer D. Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord. 13:1998;400-405.
21. De Rijk M.C., Breteler M.M., Graveland G.A.et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 45:1995;2143-2146.
22. Mastaglia F.L., Grainger K., Kee F., Sadka M., Lefroy R. Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome) clinical and electrophysiological observations in eleven cases. Proc Aust Assoc Neurol. 10:1973;35-44.
23. Radhakrishnan K., Thacker A.K., Maloo J.C., Gerryo S.E., Mousa M.E. Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology. 7:1988;159-164.
24. Rajput A.H., Offord K.P., Beard C.M., Kurland L.T. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 16:1984;278-282.
25. Steele J.C., Richardson J.C., Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 10:1964;333-359.
26. Rybicki B.A., Johnson C.C., Gorell J.M. Demographic differences in referral rates to neurologists of patients with suspected Parkinson's disease: implications for case-control study design. Neuroepidemiology. 14:1995;72-81.
27. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.